Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Cancer Cell|December 30, 2022
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillanceVito Amodio, Simona Lamba, Rosaria Chilà, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2023
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal CancerGiorgio Patelli, Gianluca Mauri, Federica Tosi, et al.Scientific Reports|June 5, 2026
Absence of co-occurrence between HER2 amplification and dMMR/MSI in a large multicentric colorectal cancer cohortAnnalice Gandini, Federica Tosi, Luca Carmisciano, et al.Cancer Immunology Research|February 27, 2019
Combined Low Densities of FoxP3<sup>+</sup> and CD3<sup>+</sup> Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of ProgressionTommaso Cavalleri, Paolo Bianchi, Gianluca Basso, et al.Journal of Clinical Pathology|May 27, 2018
TRKA expression and <i>NTRK1</i> gene copy number across solid tumoursGianluca Mauri, Emanuele Valtorta, Giulio Cerea, et al.JAMA Network Open|April 9, 2024
Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer: A Nonrandomized Controlled TrialDavide Ciardiello, Erika Martinelli, Teresa Troiani, et al.Nature Medicine|August 1, 2022
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trialAndrea Sartore-Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.Cell Reports. Medicine|January 16, 2024
Tolerance to colibactin correlates with homologous recombination proficiency and resistance to irinotecan in colorectal cancer cellsAlberto Sogari, Emanuele Rovera, Gaia Grasso, et al.British Journal of Cancer|June 6, 2022
Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients: does primary tumour location matter?Roberto Moretto, Andrew Elliott, Daniele Rossini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 26, 2022
Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal CancerErika Durinikova, Nicole M Reilly, Kristi Buzo, et al.Pageof 5